Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injectionsF Kraeber-Bodéré, A Faivre-Chauvet, C Saï-Maurel, et al.Bioconjugate Chemistry|January 20, 2005
Synthesis of new bivalent peptides for applications in the Affinity Enhancement SystemL Morandeau, E Benoist, A Loussouarn, et al.International Journal of Pharmaceutics|June 27, 2007
Doubly radiolabeled liposomes for pretargeted radioimmunotherapyM Mougin-Degraef, C Bourdeau, E Jestin, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1996
Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancerM Bardiès, S Bardet, A Faivre-Chauvet, et al.The Journal of Clinical Endocrinology and Metabolism|December 2, 2004
High frequency of bone/bone marrow involvement in advanced medullary thyroid cancerE Mirallié, J P Vuillez, S Bardet, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Validation of 213Bi-alpha radioimmunotherapy for multiple myelomaO Couturier, A Faivre-Chauvet, I V Filippovich, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 22, 2020
Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot studyY Touchefeu, C Bailly, E Frampas, et al.Pageof 3